×
Hero Background

Pancreatic cancer Companies

ID: MRFR/HC/1107-HCR
200 Pages
Rahul Gotadki
October 2025

At the forefront of oncology research, Pancreatic Cancer companies are dedicated to developing innovative diagnostics and treatments for pancreatic cancer. These organizations play a crucial role in advancing medical solutions to combat this challenging and complex disease.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Pancreatic Cancer Market Research Report-Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Pancreatic cancer Market

Pancreatic Cancer Market

 


Latest Pancreatic Cancer Companies Updates:


Pfizer's acquisition of Biohaven Pharmaceutical Holding Company: Gains access to innovative pancreatic cancer drug candidate.


Bristol Myers Squibb's collaboration with IFM Therapeutics: Jointly developing a novel targeted therapy for pancreatic cancer.


Merck & Co.'s partnership with Velontra Biosciences: Teams up to explore potential synergies in their respective pancreatic cancer pipelines.


Eli Lilly's Zydiso (nalurimide): Approved by the FDA for second-line treatment of pancreatic cancer, expanding treatment options.


Roche's Tecentriq (atezolizumab): Received breakthrough therapy designation from the FDA for combination use in early-stage pancreatic cancer.


AstraZeneca's Imfinzi (durvalumab): Market authorization extended in Europe for maintenance treatment of resectable pancreatic cancer.


List of Pancreatic Cancer Key companies in the market:



  • Pharmacyte Biotech Inc. (U.S.)

  • ncoGenex Pharmaceuticals Inc. (U.S.)

  • Oncolytics Biotech (Canada)

  • Diffusion Pharmaceuticals (U.S.)

  • Polaris Pharmaceuticals, Inc. (U.S.)

  • Sun BioPharma, Inc. (U.S.)

  • Midatech Pharma PLC (U.K.)

  • Eli Lilly and Company (U.S.)

  • Celgene Corporation (U.S.)

  • F. Hoffmann-La Roche AG (Switzerland)

  • Amgen, Inc. (U.S.)

  • Novartis International AG (U.S.)

  • Clovis Oncology (U.S.